Gilman Hill Asset Management, LLC Amgen Inc Transaction History

Gilman Hill Asset Management, LLC

$594 Million
Q3 2024

A detailed history of Gilman Hill Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Gilman Hill Asset Management, LLC holds 748 shares of AMGN stock, worth $209,492. This represents 0.04% of its overall portfolio holdings.

Number of Shares

748

Previous 748 -0.0%

Holding current value

$209,492

Previous $233,000 3.43%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $236,475 - $287,379	-900 Reduced 54.61%	748 $233,000
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $10,754 - $12,982	-40 Reduced 2.37%	1,648 $468,000
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $7,926 - $8,942	31 Added 1.87%	1,688 $486,000
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $4,285 - $5,067	-20 Reduced 1.19%	1,657 $367,000
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $24,836 - $30,272	-110 Reduced 6.16%	1,677 $405,000
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $1.23 Million - $1.37 Million	-5,344 Reduced 74.94%	1,787 $435,000
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $61,834 - $68,404	282 Added 4.12%	7,131 $1.73 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $63,641 - $72,832	-320 Reduced 4.46%	6,849 $1.54 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $102,950 - $120,619	485 Added 7.26%	7,169 $1.53 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $277,025 - $307,340	1,186 Added 21.57%	6,684 $1.63 Million
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $133,146 - $155,160	600 Added 12.25%	5,498 $1.37 Million
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $184,788 - $220,050	854 Added 21.12%	4,898 $1.13 Million
Q3 2020 Oct 16, 2020	SELL	$234.65 - $260.95 $178,803 - $198,843	-762 Reduced 15.86%	4,044 $1.03 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $18,791 - $23,060	-95 Reduced 1.94%	4,806 $1.13 Million
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $12,392 - $16,435	-68 Reduced 1.37%	4,901 $994,000
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $98,010 - $125,977	-518 Reduced 9.44%	4,969 $1.2 Million
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $277,705 - $332,748	-1,595 Reduced 22.52%	5,487 $1.06 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $380,909 - $446,511	2,285 Added 47.63%	7,082 $1.31 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $28,034 - $31,601	-155 Reduced 3.13%	4,797 $911,000
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $56,196 - $65,598	-315 Reduced 5.98%	4,952 $964,000
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $48,175 - $54,311	-260 Reduced 4.7%	5,267 $1.09 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $92,988 - $104,445	560 Added 11.27%	5,527 $1.02 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $151,639 - $177,210	895 Added 21.98%	4,967 $847,000
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $10,971 - $12,258	-65 Reduced 1.57%	4,072 $708,000
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $692,078 - $790,167	4,137	4,137 $771,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.

Account

Gilman Hill Asset Management, LLC Amgen Inc Transaction History